SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.32+1.4%3:26 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (16788)4/24/2004 10:21:54 PM
From: Bluegreen   of 17367
 
WOW!!!!!!!!!!!!!!!!!!! ALERT!!!!!!!!!!!!!!!! WOW!!!!!!!!!!!!!! DOUBLE AND TRIPLE ALERT!!!!!!! Walk, NO, RUN to your local library that has the latest VALUE LINE and see what they say about CHIRON AND XOMA under the coverage of CHIRON!!!!!!!!!!!!!!!! HOT OFF THE PRESSES!!!!!!!!!!!!!!!!!!! WOW!!!!! WOW!!!!! WOW!!!!!! Now LISTEN UP!!!!!!!!!! According to Value Line Chiron NOW has a WEAK biopharmaceutical PIPELINE soooooooooooo, WHO DO THEY CALL????..................................XOMA!!!!!!!!!!!!AND THAT IS NOT ALL!!!!!!!!!!!!!!!!!! GUESS WHO OWNS 22% of CHIRON??????? ARE YOU READY FOR THIS???????.........YES YOU GUESSED IT.........................CITIGROUP!!!!!!! Value Line research by none other than William C. Lewittes himself!!!!!!!......date of research is April 23, 2004!!!!!! HOT OFF THE PRESSES!!!!!!! You heard it first right here Bob.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News